Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 13, Number 4—April 2007

Dispatch

Endpoints for Lymphatic Filariasis Programs

Caroline A. Grady*, Madsen Beau de Rochars†, Abdel N. Direny†, Jean Nicolas Orelus†, Joyanna Wendt*, Jeanne Radday*, Els Mathieu*, Jacquelin M. Roberts*, Thomas G. Streit‡, David G. Addiss*, and Patrick J. Lammie*Comments to Author 
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †Hopital Ste. Croix, Leogane, Haiti; ‡University of Notre Dame, Notre Dame, Indiana, USA;

Main Article

Figure 2

Prevalence of infection (microfilaremia, L1, L2, and L3) in dissected mosquitoes collected by using gravid traps in sentinel sites in Leogane Commune, Haiti. Data are aggregated on a monthly basis. Dashed lines represent annual mass drug administration intervention.

Figure 2. Prevalence of infection (microfilaremia, L1, L2, and L3) in dissected mosquitoes collected by using gravid traps in sentinel sites in Leogane Commune, Haiti. Data are aggregated on a monthly basis. Dashed lines represent annual mass drug administration intervention.

Main Article

TOP